Log on / register
Feedback | Support | My details

Comments

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial

Kenneth Rockwood email, Sherri Fay email, Mary Gorman email, Daniel Carver email and Janice E Graham email

BMC Neurology 2007, 7:26doi:10.1186/1471-2377-7-26

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated